您要查找的是不是：
- Objective To investigate the changes of renal function during carboplatin (CBDCA) combined chemotherapy in patients with ovarian carcinoma. 目的觀(guān)察應用卡鉑聯(lián)合化療過(guò)程中患者腎功能的變化。
- Carboplatin, a drug derived from cisplatin, is approved by FDA. FDA批準順鉑的衍生物-卡鉑.
- Chemotherapy was:ADR 10 mg, 5-Fu 1000 mg, Carboplatin 40mg. 化療方案如下:阿霉素10mg、5-Fu1000mg、卡鉑40mg。
- OBJECTIVE：To study the stability of carboplatin suppository. 目的：對新研制的卡鉑栓進(jìn)行穩定性實(shí)驗研究。
- Carboplatin, a drug deried from cisplatin, is approed by FDA. FDA批準順鉑的衍生物-卡鉑.
- It can not improve the inhibition ratio of tumor cell by carboplatin +MPA. 卡鉑與甲孕酮聯(lián)用時(shí)對A549細胞沒(méi)有明顯的提高生長(cháng)抑制率;不具有統計學(xué)意義;P>0.;05。
- Gemcitabine plus carboplatin was associated with "moderate aderse reactions. 二氟脫氧胞嘧啶核苷聯(lián)合卡鉑給藥伴隨有“適度的副作用?！?/li>
- Methods 26 courses of postoperative systemic CBDCA therapy were carried out in 7 patients with ovarian carcinoma. 方法選擇術(shù)后接受卡鉑聯(lián)合化療方案的卵巢癌患者7例，共觀(guān)察26個(gè)療程。
- We used POC (PYM,VCR,CBDCA) scheme to treat 48 cases of spuamous cell cancer,of which 30 were of esophageal squamous cell cancer and 18 of lung squamous cell cancer. 用POC方案（PYM，VCR，CBDCA）治療鱗狀細胞癌48例，其中食管鱗狀細胞癌30例，肺鱗癌18例。
- Carboplatin is one of the most important anticancer drugs among the second generation of platinum metal-based drugs, and widely used in clinics. 摘要卡鉑是第二代鉑類(lèi)金屬抗癌藥物最重要的藥物之一，廣泛應用于臨床。
- Methods Thirteen patients with invasive bladder cancer underwent partial cystectomy and received IIAC once during operation with high-does CBDCA and ADM. 方法13例浸潤性膀胱癌患者均行膀胱部分切除術(shù),術(shù)中同時(shí)行髂內動(dòng)脈穿刺,單次大劑量灌注卡鉑和阿霉素,行區域性化療。
- The experimental study on in vivo pharmacokinetics of carboplatin liposomes via intralymphatic vessel perfusion. 經(jīng)淋巴管灌注卡鉑脂質(zhì)體的藥代動(dòng)力學(xué)實(shí)驗研究。
- The vi ncristine, etoposide, and carboplatin (VEC) were used in the chemoreduction trea tment. 化學(xué)減容術(shù)采用長(cháng)春新堿， 卡鉑和依托箔苷（VEC）方案。
- Objective To observe the efficacy and side effects of carboplatin solution in comparison with carboplatin powder. 目的觀(guān)察國產(chǎn)卡鉑注射液的療效及毒性，并與卡鉑粉針劑比較。
- Using molecular modification to reduce the side effect, cis-platin was modified to carboplatin. 透過(guò)改造分子結構去減少副作用，順鉑被改造變成卡鉑。
- The vincristine, etoposide, and carboplatin (VEC) were used in the chemoreduction treatment. 化學(xué)減容術(shù)采用VEC方案即依托泊苷、長(cháng)春新堿和卡鉑。
- Cisplatin or carboplatin should have creatinine clearance measured at baseline and then every 3-5 years as needed. 順鉑或卡鉑的藥物治療應該有最低限度的肌酸酐清除率，根據需要每3到5年檢查一次。
- In North America, this would usually be carboplatin and in Europe it would be cisplatin. 在北美常用卡鉑，在歐洲則是順鉑。
- Smith LE et al Carboplatin（Parap lin；JM8）and etoposied as fitst line Combination therapy for small cell lung Cancer. 黃德平，唐永平等，晚期肺癌支氣管動(dòng)脈內灌注化療并放療的療效中華腫瘤雜志1990；
- Conclusions The results indicated that carboplatin combined chemotherapy could induce disturbances of renal function. 結論應用卡鉑聯(lián)合化療，可引起腎功能障礙。
